Literature DB >> 16452307

Paenidase, a novel D-aspartyl endopeptidase from Paenibacillus sp. B38: purification and substrate specificity.

Saori Takahashi1, Hironobu Ogasawara, Kazuyuki Hiwatashi, Kazuyuki Hori, Keishi Hata, Tadanori Tachibana, Yoshifumi Itoh, Toshihiro Sugiyama.   

Abstract

We discovered and characterized a novel type D-aspartyl endopeptidase (DAEP) produced extracellularly by Paenibacillus sp. B38. This bacterial DAEP of M(r) 34,798 (named paenidase) appeared to be converted into a smaller form of M(r) 34,169 by the proteolytic removal of 5 amino acid residues from the N-terminal. The intact and modified forms of the enzyme displayed essentially the same enzymatic properties. The enzyme specifically hydrolyzed succinyl-D-aspartic acid alpha-(p-nitroanilide) and succinyl-D-aspartic acid alpha-(4-methylcoumaryl-7-amide) to generate p-nitroaniline and 7-amino-4-methylcoumarin, and internally cleaved a synthetic peptide (D-A-E-F-R-H-[D-Asp]-G-S-Y) of the [D-Asp](7) amyloid beta (Abeta) protein between [D-Asp](7)-G(8). Either was totally inert to the normal Abeta peptide sequence containing L-Asp, instead of D-Asp at the 7th position. Thus, paenidase is the first DAEP from a microorganism that specifically recognizes an internal D-Asp residue to cleave [D-Asp]-X peptide bonds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452307     DOI: 10.1093/jb/mvj016

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  1 in total

1.  Site-specific rapid deamidation and isomerization in human lens αA-crystallin in vitro.

Authors:  Takumi Takata; Seongmin Ha; Tamaki Koide; Noriko Fujii
Journal:  Protein Sci       Date:  2020-01-16       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.